AETHLON MEDICAL, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value (Deprecated 2013-01-31)
AETHLON MEDICAL, INC. (AEMD) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value (Deprecated 2013-01-31) of $355.58 thousand for the 12-month period ending 2013-03-31, per its 10-K filed 2013-07-15.
Discontinued › Notes › Compensation Related Costs
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodFairValue · last filed 2013-07-15
- AETHLON MEDICAL, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value (deprecated 2013-01-31) for the quarter ending 2013-03-31 was $97.11K, a 83.94% increase year-over-year.
- AETHLON MEDICAL, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value (deprecated 2013-01-31) for the quarter ending 2012-12-31 was $77.42K, a 19.53% increase year-over-year.
- AETHLON MEDICAL, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value (deprecated 2013-01-31) for the quarter ending 2012-09-30 was $128.57K, a 0.95% increase year-over-year.
- AETHLON MEDICAL, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value (deprecated 2013-01-31) for the quarter ending 2012-06-30 was $52.48K.
- AETHLON MEDICAL, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value (deprecated 2013-01-31) for fiscal 2013 was $355.58K, a 4.49% decline from fiscal 2012.
- AETHLON MEDICAL, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value (deprecated 2013-01-31) for fiscal 2012 was $372.30K.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value (Deprecated 2013-01-31) 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value (Deprecated 2013-01-31) 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value (Deprecated 2013-01-31) 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value (Deprecated 2013-01-31) 12 month |
|---|---|---|---|---|
| 2013-03-31 | $97.11K derived: 10-K 12 month − 10-Q 9 month · filed 2013-07-15 | $174.53K derived: sum of 2 quarters · filed 2013-07-15 | $303.10K derived: sum of 3 quarters · filed 2013-07-15 | $355.58K 10-K · filed 2013-07-15 |
| 2012-12-31 | $77.42K 10-Q · filed 2013-02-12 | $205.99K derived: sum of 2 quarters · filed 2013-02-12 | $258.47K 10-Q · filed 2013-02-12 | $311.26K derived: sum of 4 quarters · filed 2013-07-15 |
| 2012-09-30 | $128.57K 10-Q · filed 2012-11-13 | $181.05K 10-Q · filed 2012-11-13 | $233.84K derived: sum of 3 quarters · filed 2013-07-15 | $298.61K derived: sum of 4 quarters · filed 2013-07-15 |
| 2012-06-30 | $52.48K derived: 10-K 12 month − 3 quarters · filed 2013-07-15 | $105.27K derived: sum of 2 quarters · filed 2013-07-15 | $170.04K derived: sum of 3 quarters · filed 2013-07-15 | $297.40K derived: sum of 4 quarters · filed 2013-07-15 |
| 2012-03-31 | $52.79K derived: 10-K 12 month − 10-Q 9 month · filed 2013-07-15 | $117.57K derived: sum of 2 quarters · filed 2013-07-15 | $244.93K derived: sum of 3 quarters · filed 2013-07-15 | $372.30K 10-K · filed 2013-07-15 |
| 2011-12-31 | $64.77K 10-Q · filed 2013-02-12 | $192.14K derived: sum of 2 quarters · filed 2013-02-12 | $319.50K 10-Q · filed 2013-02-12 | |
| 2011-09-30 | $127.36K 10-Q · filed 2012-11-13 | $254.73K 10-Q · filed 2012-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |